KRTL Holding Group Reports 2024 Financial Results and

New Post Public Reply Private Reply Replies (0) Message Board
wayno2
211
KRTL Holding Group Reports 2024 Financial Results and Advances Toward International Pharmaceutical Integration
Press Release | 03/31/2025
KRTL Holding Group, Inc. (OTC: KRTL), a diversified holding company with subsidiaries engaged in pharmaceutical consulting, regulatory compliance, and international commercialization, today reported its financial results for the year ended December 31, 2024, and outlined its strategic roadmap for 2025.



Operational & Strategic Milestones



Strategic Merger Initiated: KRTL Biotech signed a Memorandum of Understanding (MOU) with Bolivia-based Industria Químico Farmacéutica Sigma Corp. S.R.L., initiating a formal international merger process and integrated manufacturing expansion.
Regulatory Compliance Strengthened: Maintained FDA registration for KRTL Biotech's operational platform and implemented a robust Quality Management System (QMS), aligning with international regulatory standards.
Market Expansion Efforts: Attracted interest from U.S. and South American pharmaceutical manufacturers seeking entry to the U.S. via KRTL Biotech's compliance infrastructure for faster, regulation-aligned distribution.
Enhanced Internal Capabilities: Expanded internal teams in legal, accounting, and strategic advisory to support governance, licensing, and market entry advisory services.


Looking Ahead – KRTL Strengthens Global Infrastructure



In 2025, KRTL continues to evolve with international production capabilities and scalable regulatory support. The Company's FDA-anchored regulatory foundation, expanding QMS, and growing pharmaceutical network position it to offer high-value services and products, including:



U.S. Market Entry Support: Assisting foreign manufacturers in leveraging KRTL's FDA-registered subsidiary and quality systems for streamlined entry into the U.S. market.
API Sourcing and Oversight: Managing formulation, labeling, and sourcing in partnership with GMP-certified manufacturers in the U.S. and South America, supported by bilateral logistics frameworks and FDA documentation protocols.
Regulatory Consulting & Licensing: Providing strategic regulatory guidance and licensing support to early-stage pharmaceutical and nutraceutical companies, ensuring 21 CFR, DEA, and international compliance alignment.
Revenue-Sharing & Commercialization: Facilitating product commercialization and revenue-sharing partnerships under the KRTL umbrella, including current product launches and licensing structures.


CEO Cesar Herrera commented: "KRTL is creating new opportunities for partners, international consultants, and global investors by actively identifying undervalued assets and leveraging the company's expertise in regulatory and operational frameworks. The company continues to pursue mergers and acquisitions, strategically evaluating and stacking candidates that align with its long-term growth vision. Recent achievements, including FDA registration, implementation of a Quality Management System (QMS), and the merger with SIGMA, validate KRTL's unique infrastructure, which enables scalable compliance, robust revenue generation, and expanded access to global markets. We expect 2025 to be a transformative year for the company."



2024 Financial Highlights



Net Income: Achieved net income of $887,587, compared to a net loss of $71,077 in 2023.
Earnings Per Share (EPS): Reported EPS of $0.01 for 2024, versus $0.00 in the prior year.
Non-Cash Revenue: Recognized non-cash revenue of $2.6 million for services provided in exchange for marketable securities.
Investment Asset Growth: Increased investment asset value to $1.54 million at year-end 2024, up from $380,000 in 2023.
Capital Structure: Maintained a streamlined capital structure with 87.2 million shares of common stock issued and outstanding.


This financial turnaround reflects early gains from cross-border licensing strategy, regulatory platform scalability, and international manufacturing synergies.



For additional disclosure



Please refer to the Annual Report for the year ended December 31, 2024, filed on otcmarkets.com/KRTL.



About KRTL Holding Group Inc.



KRTL Holding Group Inc. is a dynamic holding company operating through its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. These subsidiaries specialize in biopharmaceutical innovation, international trade, and compliance-driven healthcare advancements. By leveraging strategic mergers, acquisitions, and joint ventures, KRTL Holding Group continues to push the boundaries of scientific research, regulatory compliance, and global business solutions.



Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AR Cards in Casino Gaming: A High-Stakes Revolution

Updated Category News Views 31

A New Breed of Casino Experience Walk into a casino today, and you might just enter a whole new reality. No, this isn’t a cheesy magician’s trick or a glitzy PR stunt—this is the real deal brought to you by augmented reality (AR) trading cards. Imagine the slots you love wrapped in a sci-fi movie where characters leap out, tap you on the shoulder, and call you by...

Continue Reading
Stephanie L. Beiermann Shines in HR Consulting Honors

Updated Category News Views 61

Celebrating a Star in Payroll Optimization Ah, the name Stephanie L. Beiermann’s been making the rounds lately, catching eyes with her lauded expertise in payroll optimization and human resources. This recognition doesn’t come out of thin air—no, it’s anchored on a solid foundation of over 25 years of cutting through the fluff to sharpen operational edges. We’re...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 48

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 35

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
Hermes AI: A New Era in Market Analysis?

Updated Category News Views 44

Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...

Continue Reading
Kinross Gold Faces Class Action Over Misleading Forecasts

Updated Category News Views 51

A Golden Opportunity Gone Wrong Well, it looks like Kinross Gold Corporation (NYSE: KGC) has stuck its foot in it again. This time, they're in hot water over claims that don't exactly hold up under scrutiny. If you're holding KGC, you've probably heard about the fresh class action lawsuit alleging they misled investors about their production targets. Naturally, the...

Continue Reading
NVCA Refreshes Key Venture Legal Documents for 2026

Updated Category News Views 71

Keeping Pace with Evolving Venture Norms Change never lets up in the fast-paced world of venture capital, does it? Just when you think you've got the rules figured out, the game shifts. This time, it's the National Venture Capital Association (NVCA) shaking things up. They've given a facelift to seven of their model legal documents, a move that reshapes the legal...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 55

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
Older Adults Embrace Cosmetic Dentistry for Confidence

Updated Category News Views 139

Why the Shift to Cosmetic Dentistry Later in Life? Aging doesn't just wrinkle your skin; it affects your smile too. Dr. Joseph T. Sumrall and Dr. Gran Sumrall, the dental gurus of Warner Robins, Georgia, are laying out why more adults are jumping on the cosmetic dentistry bandwagon as they age. Spoiler: It ain't about getting a movie-star grin but something much deeper....

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 124

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading

Top 5 Most Recently Viewed Articles

Cytek Biosciences Prepares for Q2 2025 Financial Results Report

Updated Category News Views 214

Cytek Biosciences Plans Financial Disclosure for Second Quarter 2025 Cytek Biosciences, Inc. (NASDAQ: CTKB), based in Fremont, California, has dynamic news for stakeholders. The company is set to disclose its financial results for the second quarter of 2025 on August 6, 2025. This critical deadline follows the market closure that day, allowing for a comprehensive analysis...

Continue Reading
Alliance Trust PLC Shares Up: Latest NAV Per Share Insights

Updated Category News Views 171

Alliance Trust PLC Alliance Trust PLC's recent trading data dropped some key numbers that had traders buzzing. The Net Asset Value (NAV) per ordinary share hit the screens, giving everyone a fresh angle on how the company was really performing in a choppy market. NAV Breakdown: What's It Telling Us? Here's how the NAV shook out on the latest report: Valued on a Bid Price...

Continue Reading
Man Group Investment Insights: Spirent Communications and Trends

Updated Category News Views 199

Investment Insights from Man Group regarding Spirent Communications In today’s evolving market, understanding the dynamics between significant firms like Man Group PLC and Spirent Communications plc is vital for investors. This disclosure provides a snapshot of Man Group’s holdings and interests, particularly in relation to investing more than 1% in relevant...

Continue Reading
Sunny Lowe Joins Prime Mining Corp's Board of Directors

Updated Category News Views 221

Prime Mining Corp. (TSX: PRYM) (Other OTC: PRMNF) (Frankfurt: O4V3) has recently appointed Sunny Lowe to its Board of Directors. This announcement highlights a strategic move by the company to strengthen its leadership team as it continues its key projects, particularly the Los Reyes Project. Welcome to Sunny Lowe Murray John, Chair of the Board, expressed enthusiasm...

Continue Reading
Spotlight on Magnificent 7 Stocks: Opportunities in a Turbulent Market

Updated Category News Views 190

Market Overview: Understanding the Current Landscape The technology sector has seen major fluctuations recently, prompting discussions about the best investment opportunities. Economic uncertainties and market instability have resulted in significant stock losses, making this a pivotal moment for investors. The backdrop of Trump’s trade policies adds another layer of...

Continue Reading